title: Palliative treatment of malignant esophageal stenosis: the role of self-expanding stent endoscopic implantation.
abstract: Endoscopic tube implantations were carried out in 40 patients with malignant stenosis of the esophagus and gastric cardia using self-expanding metallic stents. The indications for endoscopic intubation were the advanced stage of the tumor in 27 cases and risk factors that made resection inadvisable in 13 cases. In three patients, it proved impossible to implant a stent endoscopically because we were not able to pass the guide wire through the stenosis, whereas correct stent placement was achieved in 37 cases. Functional results were good in 33 patients, but four patients did not show any improvement of symptoms. Complications occurred in nine patients (24.3%): two bleedings, three neoplastic obstructions, one food obstruction, and three distal dislodgements of the prosthesis were observed, but could be readily corrected. No deaths occurred. The median survival time was 151 days (range 25-545 days). This study suggests that endoscopic placement of metallic self-expanding stents is safe and is to be preferred to plastic stents for easier implantation and lower morbidity.
authors: Unit of Thoracic and General Surgery, Department of Surgery, University of Catania, Catania, Italy.
authors: F
authors: F
authors: Mosca
authors: A
authors: A
authors: Stracqualursi
authors: T R
authors: TR
authors: Portale
authors: A
authors: A
authors: Consoli
authors: S
authors: S
authors: Latteri
mesh_terms: D000368:Aged; D002299:Cardia; D003680:Deglutition Disorders / Q000209:etiology / Q000628:therapy; D004938:Esophageal Neoplasms / Q000150:complications / Q000401:mortality; D004940:Esophageal Stenosis / Q000209:etiology / Q000628:therapy*; D004945:Esophagoscopy; D005260:Female; D006801:Humans; D007440:Intubation; D008297:Male; D008479:Mediastinal Neoplasms / Q000150:complications / Q000401:mortality; D010166:Palliative Care / Q000379:methods*; D015607:Stents / Q000009:adverse effects; D013274:Stomach Neoplasms / Q000150:complications / Q000401:mortality; D015996:Survival Rate